title: Citalopram-induced photopigmentation.
abstract: Citalopram is one of the newer and most potent selective serotonin re-uptake inhibitor (SSRI) drugs. It has a well-established antidepressive action with a favorable adverse event profile. We present a fifty-year-old woman with diffuse photopigmentation who had been diagnosed as suffering from depression. The patient was given citalopram (40 mg/day) for her psychiatric condition and diffuse photopigmentation was noted thereafter. To our knowledge, such an adverse event has not been reported previously.
authors.affiliation: Department of Dermatology, University of Gaziantep Faculty of Medicine, Turkey.
authors.forename: H S
authors.initials: HS
authors.lastname: Inalöz
authors.forename: N
authors.initials: N
authors.lastname: Kirtak
authors.forename: H
authors.initials: H
authors.lastname: Herken
authors.forename: O
authors.initials: O
authors.lastname: Ozgöztaşi
authors.forename: A S
authors.initials: AS
authors.lastname: Aynacioğlu
mesh_terms: D015283:Citalopram / Q000009:adverse effects*; D003863:Depression / Q000188:drug therapy; D003937:Diagnosis, Differential; D005145:Face; D005260:Female; D005542:Forearm; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced / Q000175:diagnosis*; D008875:Middle Aged; D009333:Neck; D010787:Photosensitivity Disorders / Q000139:chemically induced / Q000175:diagnosis*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors